Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF APRIL 17, 2016 FBO #5259
SOURCES SOUGHT

65 -- Request for Information (RFI): Illumina NeoPrep Library System

Notice Date
4/15/2016
 
Notice Type
Sources Sought
 
NAICS
334516 — Analytical Laboratory Instrument Manufacturing
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
 
ZIP Code
20852
 
Solicitation Number
RFI-N02RC62560-24
 
Archive Date
5/4/2016
 
Point of Contact
Kimesha Leake, Phone: 2402765669, Jolomi Omatete, Phone: 2402766561
 
E-Mail Address
kimesha.leake@nih.gov, jolomi.omatete@nih.gov
(kimesha.leake@nih.gov, jolomi.omatete@nih.gov)
 
Small Business Set-Aside
N/A
 
Description
Notice Number: RFI-N02RC62560-24 Key Dates: Capability Statement Due Date: April 19, 2016 at 4:00 pm Eastern Time Issued By: National Cancer Institute (NCI), Office of Acquisitions (OA) http://www.nci.nih.gov or http://rcb.cancer.gov/rcb-internet/ General Information: This Request for Information (RFI) is to obtain knowledge and information for project planning purposes. The information gleaned for this RFI will allow NCI to develop acquisition specifications/requirements as it pertains to the purchase of an Illumina NeoPrep Library System. It should not be construed as a solicitation or as an obligation on the part of the Federal Government, the National Institutes of Health (NIH), and NCI. NCI does not intend to award a cooperative agreement, grant, or contract on the basis of responses to this RFI or to otherwise pay for the preparation of any information submitted or for the Government's use of such information. Purpose: Based on the response to this RFI, NCI may issue a solicitation at an undetermined time in the future or use the information to guide purchases of equipment, adaptation of specific methodologies or conduct specific methodological research. THERE IS NO SOLICITATION AVAILABLE AT THIS TIME, no basis for claims against NCI shall arise as a result of a response to this Request for Information notice or NCI's use of such information as either part of our evaluation process or in developing specifications for any subsequent requirement. This notice is for market research only. NCI is specifically interested in determining the types of organizations available in the marketplace that provide these technologies. In particular, NCI is seeking qualified small business concerns [including Small Disadvantaged Businesses (SDB), Woman-owned Small Businesses (WOSB), Historically Underutilized Business Zone (HUBZone) Small Businesses, Veteran-Owned Small Businesses (VOSB) and Service-Disabled Veteran-owned Small Businesses (SDVOSB) which provide these technologies. Based on the responses received from this announcement, an acquisition may be solicited as a Total Small Business Set-Aside. NAICS Code and Size Standard: In the event an RFQ is issued, North American Industry Classification System (NAICS) code 334516 with a size standard of 500 employees is being considered. Background: The Center for Cancer Research (CCR), Genomics Core, provides NCI intramural investigators with a range of genomics technologies, available either as services delivered by the Genomics Core or as walk-up access to specific instrumentation and technologies. The main purpose of the Core is to provide investigators in Bethesda with access to NGS with rapid turnaround on smaller-scale projects. Secondly, the Genomics Core provides local interactions and sharing of NGS expertise with Bethesda researchers and clinicians, who are seeking to acquire and set up their own NGS capabilities. In alignment with our goals, the Genomics Core has conducted a number of diverse projects requested by multiple CCR labs, and at least two labs that we worked with in the past are have set up their own internal NGS lab units. However, the Genomic Core has recently received multiple requests for RNAseq by users who require a short turnaround time. These customers are currently re-directed to other facilities as the Genomic Core's Government owned MiSeq instrument cannot generate sufficient number of reads to satisfy their requests. Purpose: The purpose is to procure the NeoPrep Library Prep System. The equipment will be dedicated to servicing the needs of the CCR, Genomics Core which is supported by CCR. Information Requested: I. General Information - contact information, including name, institution/organization, telephone and fax numbers and e-mail address; website URL II. Equipment and required specifications: a. The purchase will include installation of the instrument and accessories, by Illumina engineers and specialists b. protocol development and professional training of Genomics Core staff on the instrument Delivery Point: Contractor shall deliver the item within 6 weeks after award to: NIH/NCI Bethesda, Maryland 20892. How to Submit a Response: Interested qualified small business organizations should submit a tailored capability statement for this requirement not to exceed 10 single sided pages including all attachments, resumes, charts, etc. (single space, 12 point font minimum) that clearly details the ability to perform the aspects of the notice described above. Brevity and structured format (such as bulleted items) are encouraged whenever applicable to aid in processing. All proprietary information should be marked as such. Statements should also include an indication of current certified small business status; this indication should be clearly marked on the first page of your capability statement (preferable placed under the eligible small business concern's name and address). Responses will be reviewed only by NCI personnel and will be held in a confidential manner. Due Date: Capability statements are due no later than April, 19 2016 4:00 pm Eastern Time All capability statements sent in response to the Request for Information must be submitted electronically (via e-mail) to Kimesha Leake at kimesha.leake@nih.gov in MS Word, WordPerfect or Adobe Portable Document Format (PDF). All responses must be received at NCI by the specified due date and time in order to be considered. All information furnished must be in writing and must contain sufficient detail to allow NCI to determine if it can meet the unique specifications described herein. All questions must be in writing and emailed to Kimesha Leake, Contract Specialist at kimesha.leake@nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the System for Award Management (SAM) www.sam.gov. Please reference solicitation number RFI- N02RC62560-24 on all correspondences. Point of Contact: Inquiries concerning this Notice may be directed to: Kimesha Leake, Contract Specialist 9609 Medical Center Drive, room 1E626 Rockville, MD 20850 240-276-5669 kimesha.leake@nih.gov
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/RFI-N02RC62560-24/listing.html)
 
Place of Performance
Address: National Cancer Institute, Bethesda, MD 20892, Bethesda, Maryland, 20892, United States
Zip Code: 20892
 
Record
SN04085856-W 20160417/160415234529-3c876432e1ddc358e40fb0fc84dbee04 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.